However, although CBX2 downstream targets are enriched for the GO terms Kidney development, Spleen Development, and Bone Morphogenesis, no such defects have been observed in the 46,XY DSD patient, indicating that the currently known CBX2 variants in humans are not enough to disrupt the development of the kidney, spleen or skeletal system5. Here, CBX2 is linked to disorder of sexual differentiation.